Cyclacel Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 3.42K %.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Equity for 2023 was -407 %, a 389% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Equity for 2022 was -83.3 %, a 92.4% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Equity for 2021 was -43.3 %, a 21.3% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 3.42K +3.69K Jul 1, 2024 Sep 30, 2024
Q2 2024 -1.89K -1.72K -1009% Apr 1, 2024 Jun 30, 2024
Q1 2024 -841 -724 -621% Jan 1, 2024 Mar 31, 2024
Q4 2023 -407 -324 -389% Oct 1, 2023 Dec 31, 2023
Q3 2023 -264 -203 -331% Jul 1, 2023 Sep 30, 2023
Q2 2023 -171 -119 -228% Apr 1, 2023 Jun 30, 2023
Q1 2023 -117 -67.8 -139% Jan 1, 2023 Mar 31, 2023
Q4 2022 -83.3 -40 -92.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -61.1 -22.2 -57% Jul 1, 2022 Sep 30, 2022
Q2 2022 -52 -15.3 -41.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.8 -16.5 -50.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -43.3 -7.6 -21.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.9 +4.56 +10.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36.7 +11.9 +24.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -32.4 +23.5 +42% Jan 1, 2021 Mar 31, 2021
Q4 2020 -35.7 +17.6 +33% Oct 1, 2020 Dec 31, 2020
Q3 2020 -43.5 +4.88 +10.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -48.6 -1.22 -2.58% Apr 1, 2020 Jun 30, 2020
Q1 2020 -55.8 -10.1 -22% Jan 1, 2020 Mar 31, 2020
Q4 2019 -53.2 -12.1 -29.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.4 -11.5 -31% Jul 1, 2019 Sep 30, 2019
Q2 2019 -47.3 -14.4 -43.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -45.7 -8.14 -21.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -41.1 +1.76 +4.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -36.9 +17.4 +32% Jul 1, 2018 Sep 30, 2018
Q2 2018 -32.9 +35.6 +51.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -37.6 +34.5 +47.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -42.9 +35.4 +45.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -54.3 +21.8 +28.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -68.5 +1.13 +1.62% Apr 1, 2017 Jun 30, 2017
Q1 2017 -72.1 -10.1 -16.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -78.3 -15.6 -24.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -76 -9.25 -13.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -69.6 +4.15 +5.63% Apr 1, 2016 Jun 30, 2016
Q1 2016 -62 +13.5 +17.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -62.7 +14.2 +18.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -66.8 +0.9 +1.33% Jul 1, 2015 Sep 30, 2015
Q2 2015 -73.7 -8.34 -12.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -75.5 -33.2 -78.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -76.9 -35.5 -85.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -67.7 -11 -19.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -65.4 -14.2 -27.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 -42.3 +67.4 +61.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -41.4 +51.4 +55.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -56.7 +16.2 +22.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -51.2 +20.5 +28.6% Apr 1, 2013 Jun 30, 2013
Q1 2013 -110 -39.7 -56.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -92.8 Oct 1, 2012 Dec 31, 2012
Q3 2012 -72.9 Jul 1, 2012 Sep 30, 2012
Q2 2012 -71.7 Apr 1, 2012 Jun 30, 2012
Q1 2012 -70.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.